WAM
ARIA

Wealthspire Advisors (Maryland)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-137
Closed -$2K – 2104
2016
Q4 		$2K Hold
137
– – ﹤0.01% 1601
2016
Q3 		$2K Sell
137
-27
-16% -$271 ﹤0.01% 1602
2016
Q2 		$1K Hold
164
– – ﹤0.01% 1673
2016
Q1 		$1K Sell
164
-80
-33% -$448 ﹤0.01% 1713
2015
Q4 		$2K Buy
+244
New +$1.6K ﹤0.01% 1569

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ARIA Position: Q1 2017 in Review

Wealthspire Advisors (Maryland) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 137 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in ARIA in Q4 2015 and held it in 5 quarters. The position peaked at $2K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Wealthspire Advisors (Maryland) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 137 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 5 quarters.
  • Wealthspire Advisors (Maryland)'s Ariad Pharmaceuticals Inc position peaked at $2K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2017, filed 9 May 2017.